Adam Anschel

Adam Anschel is the Managing Director for MicroBioDx with a strong background spanning over 25 years in Medical Sales & Marketing, particularly focusing on Physician Owned Labs and Diagnostics.

MicroBioDx specializes in marketing a unique no-extraction molecular Covid assays for high volume users, offering turnkey consulting services including lab licensing, setup, and training. The company supplies essential equipment such as real-time PCR machines to clients ranging from urgent care chains, hospital systems, governments, corporations, and reference laboratories.

MicroBioDx's turnkey proprietary molecular testing program caters to various healthcare providers like Urgent Care, Primary Care, Urologists, OBGYNs, Internal Medicine, ENT, Podiatry, and more. Their PCR panels cover a range of tests including UTI with antibiotic resistance, Vaginitis, Respiratory, Wound, and Nail. The quick turnaround time of 1-2 hours for testing, along with high reimbursement rates, makes it a sought-after service. From equipment setup to licensing, validations, protocols, and continuous support, MicroBioDx manages all aspects of the testing program, which can be seamlessly integrated into Hospitals and Reference Laboratories.